Loading...
Derniers dépôts
-
-
Intira Collins, Kara Wools-Kaloustian, Ruth Goodall, Colette Smith, Elaine Abrams, et al.. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. The Lancet HIV, 2019, 6 (2), pp.e105-e115. ⟨10.1016/S2352-3018(18)30319-9⟩. ⟨hal-04608257⟩
-
Sophie Desmonde, Simone Frank, Ashraf Coovadia, Désiré Dahourou, Taige Hou, et al.. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 2019, 6 (7), pp.ofz276. ⟨10.1093/ofid/ofz276⟩. ⟨hal-04608242⟩
-
-
Julie Jesson, Désiré L Dahourou, Françoise Renaud, Martina Penazzato, Valériane Leroy. Adverse events associated with abacavir use in HIV-infected children and adolescents: a systematic review and meta-analysis. The Lancet HIV, 2015, 3 (2), pp.e64 - e75. ⟨10.1016/s2352-3018(15)00225-8⟩. ⟨hal-04607453⟩